Videos

Jesse C. Dresser, Esq explains how DIR fees affect specialty pharmacists at the NASP Annual Meeting in Washington, DC.

Jennifer Woyach, MD, associate professor at The Ohio State University, explains how patient-specific factors can help determine treatment decisions in chronic lymphocytic leukemia.

Jeffrey Fudin, PharmD, DAIPM, FASHP, FFSMB, CEO of Remitigate, discusses how opioid and pain management guidelines have evolved. This video was filmed at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss how Specialty Pharmacists can drive the data standardization conversation during the NASP Annual Meeting in Washington, DC.

Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss during the future of data in Specialty Pharmacy at the NASP Annual Meeting in Washington, DC.

Jesse C. Dresser, Esq explains a recent piece of PBM legislation from North Dakota and its implications for specialty pharmacy at the NASP Annual Meeting in Washington, DC.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.